BCR and prostate carcinoma: However, only a few studies explored their impacts on the progression of prostate cancer.9, 10, 11 Therefore, the present study aims to investigate whether common genetic variants in anoctamin genes are associated with BCR‐free survival, which may help identify candidate genes and provide insight into the etiology of prostate cancer progression.